| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-09-03 | SCHEDULE 13D | JATT Ventures III L.P. | 22.10% | 1,959,000 | view → |
| 2026-09-02 | SCHEDULE 13G | Deep Track Capital, LP | — | — | view → |
| 2026-09-02 | SCHEDULE 13G | GREAT POINT PARTNERS LLC | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-08-17 | SCHEDULE 13G | InflaRx N.V. | — | — | view → |
| 2026-07-20 | SCHEDULE 13G | Research Alliance Corp IV | — | — | view → |
| 2026-06-18 | SCHEDULE 13G | Avalo Therapeutics, Inc. AVTX | — | — | view → |
| 2026-06-03 | SCHEDULE 13G | EyePoint, Inc. EYPT | — | — | view → |
| 2026-06-02 | SCHEDULE 13G | Editas Medicine, Inc. EDIT | — | — | view → |
| 2026-05-28 | SCHEDULE 13G | Research Alliance Corp III RACC | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →